Steve Schonfeld’s Apogee Therapeutics APGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-31,059
Closed -$4.12M – 2792
2026
Q2
$4.12M Buy
31,059
+7,971
+35% +$718K 0.01% 724
2026
Q1
$1.94M Sell
23,088
-6,057
-21% -$440K 0.01% 829
2025
Q4
$2.2M Buy
+29,145
New +$1.84M 0.01% 842
2025
Q1
– Sell
-70,766
Closed -$3.21M – 2192
2024
Q4
$3.21M Buy
+70,766
New +$3.61M 0.02% 650

Other funds holding APGE

Steve Schonfeld's APGE Position: Q3 2026 in Review

Steve Schonfeld sold out of Apogee Therapeutics (APGE) in Q3 2026, closing a stake of 31,059 shares — an estimated $4.12M sold.

Steve Schonfeld first reported a position in APGE in Q4 2024 and held it in 4 quarters. The position peaked at $4.12M in Q2 2026. 2 funds tracked by Wall St. Rank hold APGE as of Q3 2026.

  • Steve Schonfeld reported no remaining Apogee Therapeutics position as of Q3 2026 after selling out during the quarter.
  • Steve Schonfeld sold 31,059 Apogee Therapeutics shares in Q3 2026, an estimated $4.12M.
  • Steve Schonfeld first reported a position in Apogee Therapeutics in Q4 2024 and held it in 4 quarters.
  • Steve Schonfeld's Apogee Therapeutics position peaked at $4.12M in Q2 2026.
  • 2 funds tracked by Wall St. Rank held Apogee Therapeutics as of Q3 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.